Home › Funds › Two Sigma Investments › MGX
Two Sigma Investments position in MGX
METAGENOMI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)513.70K sh
Reported value held$611.30K
Portfolio Weight0.00%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 20.16K | $212.68K | New |
| Q2 2024 | 37.69K | $153.79K | Add |
| Q3 2024 | 85.61K | $185.76K | Add |
| Q4 2024 | 26.47K | $95.56K | Reduce |
| Q1 2025 | 58.35K | $79.35K | Add |
| Q2 2025 | 13.89K | $20.55K | Reduce |
| Q3 2025 | 207.53K | $491.84K | Add |
| Q4 2025 | 441.39K | $715.05K | Add |
| Q1 2026 | 496.77K | $665.67K | Add |
| Q2 2026 | 513.70K | $611.30K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MGX
- Vanguard Group 1.27M sh · $2.06M · Q4 2025
- Renaissance Technologies 742.40K sh · $883.46K · Q2 2026
- Wells Fargo & Co 379.51K sh · $451.61K · Q2 2026
- Geode Capital Management 288.67K sh · $343.67K · Q2 2026
- BlackRock Inc 257.63K sh · $306.58K · Q2 2026
- Millennium Management 114.03K sh · $135.69K · Q2 2026
- Northern Trust Corp 68.94K sh · $82.04K · Q2 2026
- Citadel Advisors 17.85K sh · $21.24K · Q2 2026
- UBS Group AG 15.79K sh · $18.79K · Q2 2026
- Morgan Stanley 5.30K sh · $6.31K · Q2 2026
- JPMorgan Chase & Co 1.60K sh · $1.92K · Q2 2026